American Renal Associates Holdings Inc. has filed with the SEC to go public. The dialysis provider operates 181 dialysis clinic locations in 23 states and the District of Columbia through joint ventures with nephrologists. The company has applied to list its common stock on the New York Stock Exchange under the ticker symbol “ARA”.

Read also: U.S. Renal Care, DSI Renal to merge

According to Renaissance Capital, American Renal filed Aug. 31 to raise up to $100 million in an initial public offering, but they estimate the deal size is a placeholder for an IPO that could raise $300 million.

BofA Merrill Lynch, Barclays, Goldman Sachs, Wells Fargo Securities, Suntrust Robinson Humphrey are the joint bookrunners on the deal. Leerink Partners is acting as a co-manager in the proposed offering.